Putnam Investments’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$3.57M Buy
165,631
+28,448
+21% +$525K ﹤0.01% 541
2023
Q3
$2.55M Buy
137,183
+23,389
+21% +$546K ﹤0.01% 672
2023
Q2
$2.88M Buy
113,794
+15,090
+15% +$380K ﹤0.01% 662
2023
Q1
$2.56M Sell
98,704
-21,444
-18% -$574K ﹤0.01% 667
2022
Q4
$2.84M Buy
+120,148
New +$3.24M 0.01% 664
2022
Q2
Sell
-52,814
Closed -$3.81M 1218
2022
Q1
$3.81M Buy
52,814
+1,330
+3% +$95.8K 0.01% 678
2021
Q4
$4.73M Sell
51,484
-18,372
-26% -$2.2M 0.01% 560
2021
Q3
$8.86M Buy
69,856
+262
+0.4% +$38.1K 0.01% 387
2021
Q2
$11.6M Sell
69,594
-25,287
-27% -$4.1M 0.02% 338
2021
Q1
$17.2M Buy
94,881
+3,358
+4% +$779K 0.03% 277
2020
Q4
$18.3M Buy
91,523
+11,433
+14% +$2.32M 0.03% 257
2020
Q3
$17.6M Buy
80,090
+48,500
+154% +$10.3M 0.03% 258
2020
Q2
$6.03M Sell
31,590
-75,283
-70% -$13.2M 0.01% 427
2020
Q1
$16.6M Sell
106,873
-58,736
-35% -$6.83M 0.04% 239
2019
Q4
$13.9M Sell
165,609
-16,858
-9% -$1.28M 0.03% 303
2019
Q3
$12.4M Sell
182,467
-27,042
-13% -$1.78M 0.03% 328
2019
Q2
$13.9M Sell
209,509
-2,129
-1% -$124K 0.03% 308
2019
Q1
$11.8M Sell
211,638
-985
-0.5% -$60.1K 0.03% 323
2018
Q4
$10.5M Buy
212,623
+11,187
+6% +$685K 0.03% 311
2018
Q3
$17.4M Buy
201,436
+37,396
+23% +$2.67M 0.04% 288
2018
Q2
$9.52M Sell
164,040
-117,440
-42% -$5.74M 0.02% 379
2018
Q1
$11.3M Buy
+281,480
New +$10.6M 0.03% 349

Other funds holding TDOC

Putnam Investments's TDOC Position: Q4 2023 in Review

Putnam Investments increased its Teladoc Health (TDOC) stake by 21% in Q4 2023, buying an estimated $525K and bringing the position to 165,631 shares worth $3.57M. The position accounts for ﹤0.01% of the portfolio, ranked #541.

Putnam Investments first reported a position in TDOC in Q1 2018 and has held it in 22 quarters since. The position peaked at $18.3M in Q4 2020. 436 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

  • Putnam Investments held 165,631 shares of Teladoc Health worth $3.57M as of Q4 2023.
  • Putnam Investments bought 28,448 Teladoc Health shares in Q4 2023, an estimated $525K.
  • Teladoc Health made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #541 holding.
  • Putnam Investments first reported a position in Teladoc Health in Q1 2018 and has held it in 22 quarters since.
  • Putnam Investments's Teladoc Health position peaked at $18.3M in Q4 2020.
  • 436 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.